Table 5 Cardiotoxicity treatment: pre-and-post 2012 ESMO Guidelines [26]
From: Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Date of cardiotoxicity diagnosis | 1994–2011 (n = 14)a | 2012–2015 (n = 31)a | Change | P value |
|---|---|---|---|---|
Referred to cardiologist (pre-chemotherapy) | 0 (0%) | 7 (37%) | ↑ 37% | 0.060 |
Referred to cardiologist (any) | 8 (57%) | 19 (61%) | ↑ 4% | 0.793 |
Baseline ECHO undertaken | 8 (57%) | 23 (72%) | ↑ 15% | 0.253 |
Died during study period | 6 (43%) | 10 (32%) | ↓ 11% | 0.492 |